246 related articles for article (PubMed ID: 36869369)
21. Use of monoclonal antibody against human inhibin as a marker for sex cord-stromal tumors of the ovary.
Rishi M; Howard LN; Bratthauer GL; Tavassoli FA
Am J Surg Pathol; 1997 May; 21(5):583-9. PubMed ID: 9158684
[TBL] [Abstract][Full Text] [Related]
22. Prognostic factors of ovarian granulosa cell tumor: a study of 35 patients and review of the literature.
Auranen A; Sundström J; Ijäs J; Grénman S
Int J Gynecol Cancer; 2007; 17(5):1011-8. PubMed ID: 17374124
[TBL] [Abstract][Full Text] [Related]
23. The FOXL2 C134W mutation is characteristic of adult granulosa cell tumors of the ovary.
Jamieson S; Butzow R; Andersson N; Alexiadis M; Unkila-Kallio L; Heikinheimo M; Fuller PJ; Anttonen M
Mod Pathol; 2010 Nov; 23(11):1477-85. PubMed ID: 20693978
[TBL] [Abstract][Full Text] [Related]
24. 14-3-3 sigma is a useful immunohistochemical marker for diagnosing ovarian granulosa cell tumors and steroid cell tumors.
Chen L; Yang B
Int J Gynecol Pathol; 2013 Mar; 32(2):156-62. PubMed ID: 23370648
[TBL] [Abstract][Full Text] [Related]
25. Granulosa cell tumor of the ovary. Immunohistochemical evidence of low proliferative activity and virtual absence of mutation of the p53 tumor-suppressor gene.
Horny HP; Marx L; Kröber S; Lüttges J; Kaiserling E; Dietl J
Gynecol Obstet Invest; 1999; 47(2):133-8. PubMed ID: 9949285
[TBL] [Abstract][Full Text] [Related]
26. The molecular mechanism of ovarian granulosa cell tumors.
Li J; Bao R; Peng S; Zhang C
J Ovarian Res; 2018 Feb; 11(1):13. PubMed ID: 29409506
[TBL] [Abstract][Full Text] [Related]
27. FOXL2 Mutation Status in Granulosa Theca Cell Tumors of the Ovary.
Nolan A; Joseph NM; Sangoi AR; Rabban J; Zaloudek C; Garg K
Int J Gynecol Pathol; 2017 Nov; 36(6):568-574. PubMed ID: 28319575
[TBL] [Abstract][Full Text] [Related]
28. Smad1-Smad5 ovarian conditional knockout mice develop a disease profile similar to the juvenile form of human granulosa cell tumors.
Middlebrook BS; Eldin K; Li X; Shivasankaran S; Pangas SA
Endocrinology; 2009 Dec; 150(12):5208-17. PubMed ID: 19819941
[TBL] [Abstract][Full Text] [Related]
29. Mutational analysis (c.402C>G) of the FOXL2 gene and immunohistochemical expression of the FOXL2 protein in testicular adult type granulosa cell tumors and incompletely differentiated sex cord stromal tumors.
Hes O; Vaněček T; Petersson F; Grossmann P; Hora M; Perez Montiel DM; Steiner P; Dvořák M; Michal M
Appl Immunohistochem Mol Morphol; 2011 Jul; 19(4):347-51. PubMed ID: 21293260
[TBL] [Abstract][Full Text] [Related]
30. Anti-Müllerian hormone inhibits growth of AMH type II receptor-positive human ovarian granulosa cell tumor cells by activating apoptosis.
Anttonen M; Färkkilä A; Tauriala H; Kauppinen M; Maclaughlin DT; Unkila-Kallio L; Bützow R; Heikinheimo M
Lab Invest; 2011 Nov; 91(11):1605-14. PubMed ID: 21808236
[TBL] [Abstract][Full Text] [Related]
31. Granulosa Cell Tumors: Novel Predictors of Recurrence in Early-stage Patients.
Sakr S; Abdulfatah E; Thomas S; Al-Wahab Z; Beydoun R; Morris R; Ali-Fehmi R; Bandyopadhyay S
Int J Gynecol Pathol; 2017 May; 36(3):240-252. PubMed ID: 28727617
[TBL] [Abstract][Full Text] [Related]
32. Serum Müllerian Inhibiting Substance/anti-Müllerian hormone levels in patients with adult granulosa cell tumors directly correlate with aggregate tumor mass as determined by pathology or radiology.
Chang HL; Pahlavan N; Halpern EF; MacLaughlin DT
Gynecol Oncol; 2009 Jul; 114(1):57-60. PubMed ID: 19359032
[TBL] [Abstract][Full Text] [Related]
33. Predictors of recurrence of ovarian granulosa cell tumors.
Nosov V; Silva I; Tavassoli F; Adamyan L; Farias-Eisner R; Schwartz PE
Int J Gynecol Cancer; 2009 May; 19(4):628-33. PubMed ID: 19509561
[TBL] [Abstract][Full Text] [Related]
34. The value of cell proliferation and angiogenesis in the prognostic assessment of ovarian granulosa cell tumors.
Jurić G; Zarković N; Nola M; Tillian M; Jukić S
Tumori; 2001; 87(1):47-53. PubMed ID: 11669558
[TBL] [Abstract][Full Text] [Related]
35. [Juvenile granulosa-cell tumor: clinical and molecular expression].
Kalfa N; Philibert P; Patte C; Thibaud E; Pienkowski C; Ecochard A; Boizet-Bonhoure B; Fellous M; Sultan C
Gynecol Obstet Fertil; 2009 Jan; 37(1):33-44. PubMed ID: 19119048
[TBL] [Abstract][Full Text] [Related]
36. Granulosa cell tumor of the ovary.
Schumer ST; Cannistra SA
J Clin Oncol; 2003 Mar; 21(6):1180-9. PubMed ID: 12637488
[TBL] [Abstract][Full Text] [Related]
37. FOXL2 molecular testing in ovarian neoplasms: diagnostic approach and procedural guidelines.
Kommoss S; Anglesio MS; Mackenzie R; Yang W; Senz J; Ho J; Bell L; Lee S; Lorette J; Huntsman DG; Blake Gilks C
Mod Pathol; 2013 Jun; 26(6):860-7. PubMed ID: 23348906
[TBL] [Abstract][Full Text] [Related]
38. Expression status and mutational analysis of the PTEN and P13K subunit genes in ovarian granulosa cell tumors.
Bittinger S; Alexiadis M; Fuller PJ
Int J Gynecol Cancer; 2009 Apr; 19(3):339-42. PubMed ID: 19407556
[TBL] [Abstract][Full Text] [Related]
39. Ovarian granulosa cell tumor and clomiphene citrate resistance. A case report and review of the literature.
Triantafyllidou O; Sigalos G; Oikonomou I; Vlahos N
JBRA Assist Reprod; 2018 Nov; 22(4):381-384. PubMed ID: 30141889
[TBL] [Abstract][Full Text] [Related]
40. Aromatase is a direct target of FOXL2: C134W in granulosa cell tumors via a single highly conserved binding site in the ovarian specific promoter.
Fleming NI; Knower KC; Lazarus KA; Fuller PJ; Simpson ER; Clyne CD
PLoS One; 2010 Dec; 5(12):e14389. PubMed ID: 21188138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
